Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hieber's Pharmacy
WARNING LETTER
•Hieber's Pharmacy•September 18, 2014

Hieber's Pharmacy – FDA Warning Letter, Sep 18, 2014

Record Details

On September 29, 2015, the FDA issued a Warning Letter to Hieber's Pharmacy following an inspection from September 8-18, 2014. The inspection revealed the pharmacy was producing drug products without valid prescriptions for individually-identified patients and compounding domperidone products.

These actions violate the Federal Food, Drug, and Cosmetic Act (FDCA). Compounded drugs without individual prescriptions and those containing domperidone are not exempt under FDCA Section 503A, as domperidone is not a USP/NF monograph subject, an FDA-approved drug component, or on the Secretary's approved bulk drug list.

Consequently, these drugs are considered misbranded under Section 502(f)(1) because they lack adequate directions for use for a layman. Furthermore, the manufacture of drugs without individual prescriptions subjects the firm to FDA's Current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211).

Significant CGMP violations were observed, rendering the drugs adulterated under Section 501(a)(2)(B). Violations included failure to establish procedures to prevent microbiological contamination (21 CFR 211.113(b)), lack of laboratory determination of conformance to specifications for sterile products (21 CFR 211.167(a)), inadequate stability testing programs (21 CFR 211

Company
Hieber's Pharmacy
Inspection date
September 18, 2014
Product type
Drugs
Office
Philadelphia District Office
Person
  • Anne E. Johnson (Senior Science Advisor)
View Company Profile

ID · a623f549-7135-4f94-81ab-ba8555fa21a1

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a(b)(1)(A)(i)(III)21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(k)21 CFR 21021 CFR 21121 CFR 211.113(b)21 CFR 211.167(a)

Full citation text and observation details available on the Dashboard.

Other documents for Hieber's Pharmacy
  • WARNING_LETTER - 2017-02-17February 17, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hieber's Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.